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was a history of intimate contact with a family member with
a history of leprosy 6 years before the onset of the patient’s
symptoms. A prior research for leprosy with a skin biopsy
resulted negative.vailable online xxx
ntroduction
eprosy is a chronic infectious disease caused by Mycobac-
erium leprae,  being highly contagious but with low morbidity
ue to the resistance of a good part of the population to this
isease. Its worldwide prevalence has declined since the intro-
uction of multidrug chemotherapy; but despite this, Brazil
as not achieved the goal of eliminating the disease, being
econd only to India in the absolute number of cases.1 Leprosy
resents a broad spectrum of clinical manifestations and can
e a diagnostic challenge, especially in the early years of the
isease. Some of these manifestations resemble the clinical
icture of certain rheumatologic diseases.2,3 We report a case
f leprosy with skin thickening, distal phalanx resorption, and
acial telangiectasia, simulating systemic sclerosis.Please cite this article in press as: Burko Rocha Chu B, et al. Leprosy sim
http://dx.doi.org/10.1016/j.rbre.2016.09.010
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icenses/by-nc-nd/4.0/).Case  report
Male patient, 69 years, with clinical manifestations that
started 4 years ago with sclerodactyly associated with an
unrelated-to-cold cyanosis and pallor in his extremities, with
no history of digital ulceration, but with progressive resorption
of distal phalanges evidenced in the clinical progression. The
patient still had symptoms of sensitive polyneuropathy in his
hands and feet and telangiectasias on the face. A year before
diagnosis, hypoesthesic skin lesions on elbows appeared. The
patient had no joint complaints, dyspnea or dysphagia. Thereulating systemic sclerosis: a case report. Rev Bras Reumatol. 2016.
l de Clínicas, Servic¸o de Reumatologia, Curitiba, PR, Brazil.
e under the CC BY-NC-ND license (http://creativecommons.org/
ARTICLE IN PRESSRBRE-327; No. of Pages 3
2  r e v b r a s r e u m a t o l . 2 0
Fig. 1 – Skin thickening and resorption of distal phalanges.
Fig. 2 – Radiography of the patient’s hands showing
acro-osteolysis.In the current evaluation, distal skin and ulnar nerve
bilateral thickening, resorption of distal phalanges (Fig. 1),
telangiectasias on the face, as well as hypoesthesic lesions
with inﬁltration and erythema on both elbows were evidenced.
Laboratory tests were normal and a radiography of his hands
showed bone resorption of distal phalanges (Fig. 2). Capil-
laroscopy was not performed. The patient underwent a new
biopsy, which conﬁrmed the diagnosis of tuberculoid leprosy.
The patient was instructed with regard to subsequent treat-
ment and that his close contacts should be evaluated, and
proceeds with his dermatological treatment.
DiscussionPlease cite this article in press as: Burko Rocha Chu B, et al. Leprosy sim
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Leprosy results in several clinical manifestations that depend
on the host immune response. In tuberculoid leprosy, there 1 6;x  x x(x x):xxx–xxx
is an efﬁcient cell-mediated response, while lepromatous
(Virchowian) leprosy is characterized by humoral immunity.
Between these two extremes, intermediate forms are seen that
reﬂect the gradual variation in resistance against the bacillus.4
In the early stages, the patient may present with only skin
and neurological symptoms, showing no signs of involve-
ment of other organs.2 The musculoskeletal involvement is
the third most common symptom.5 In a study of 70 patients
with leprosy, Vengadakrishnan et al. showed that 61.42% of
patients showed rheumatological manifestations, the most
common of them being arthritis.6 On the other hand, a Brazil-
ian study showed that only 6.1% of 1257 leprosy patients had
joint involvement.7
Systemic symptoms and the presence of autoantibodies
can also occur.2 Ribeiro et al. determined the antibody proﬁle
of 158 leprosy patients, with and without joint involvement.
The frequency of anticardiolipin and anti-beta 2 glycoprotein
I antibodies was signiﬁcantly higher in leprosy patients ver-
sus healthy controls.8 Elbeialy et al. demonstrated that the
presence of anticardiolipin antibodies was associated with the
presence of Raynaud’s phenomenon in patients with leprosy.9
In the literature, leprosy cases misdiagnosed as systemic
lupus erythematosus, vasculitis, rheumatoid arthritis,3 and
systemic sclerosis have been described. The latter is an
autoimmune disorder that causes excessive accumulation of
collagen, causing skin sclerosis and ﬁbrosis of internal organs.
Lee et al. also reported a case of leprosy simulating systemic
sclerosis. The patient was mistakenly diagnosed with this dis-
ease, due to the similarity of skin lesions, the presence of
Raynaud’s phenomenon, and the positivity of some antibod-
ies. The skin thickening was subsequently interpreted as a
longstanding skin edema secondary to leprosy plates, and not
as true scleroderma.2
Initially, the patient described in this study was diagnosed
as a systemic sclerosis carrier by presenting skin thickening
in his hands, Raynaud’s phenomenon, telangiectasias, and
resorption of the distal phalanges, and also due to the fact
an initial skin biopsy has not shown the presence of acid-
fast bacilli. Resorption of distal phalanx occurs in 20–25% of
patients with systemic sclerosis, and this ﬁnding is strongly
associated with severe digital ischemia, suggesting that this is
due to ischemic atrophy.10 In leprosy, the changes of the distal
phalanx can be of various types, for instance, a focal defect,
irregularity, complete destruction, or concentric narrowing,
occurring in 19–45% of patients.11
Despite several symptoms common to these two  condi-
tions presented by our patient, we  also found anesthesia of
“Stocking-Glove” Pattern, and the involvement of signals from
other organs, as evidenced by the absence of dysphagia and
dyspnea, and by pulmonary function tests which were within
the normal range. Thus, leprosy was shown as the most likely
diagnosis, which was conﬁrmed by another skin biopsy.
Leprosy still has considerable prevalence in Brazil, and the
delay in its diagnosis and treatment can result in deformi-
ties and functional impairment. Besides arthritis, the disease
has many  other laboratory and clinical similarities with
autoimmune diseases. Thus, rheumatologists should considerulating systemic sclerosis: a case report. Rev Bras Reumatol. 2016.
leprosy as a diagnostic hypothesis in patients with mus-
culoskeletal involvement, particularly if such patients are
showing an involvement of peripheral nerves.
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